Pulse Biosciences (PLSE)

• Market cap: $1.05B
• 1 day: -1.72%
• 5 days: -7.98%
• 1 month: -22.19%
• 3 months: 5.03%
• 6 months: -7.37%
• Year to date: -13.1%
• 1 year: -14.02%
• 5 years: 30.03%
• 10 years: 270.74%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Employees: 75